Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7M Sell
196,922
-180,502
-48% -$20.8M 0.32% 60
2025
Q4
$39.7M Sell
377,424
-108,415
-22% -$10.2M 0.46% 42
2025
Q3
$40.8M Buy
485,839
+149,928
+45% +$12.3M 0.5% 42
2025
Q2
$26.6M Sell
335,911
-8,513
-2% -$677K 0.37% 59
2025
Q1
$30.9M Sell
344,424
-24,363
-7% -$2.27M 0.48% 43
2024
Q4
$36.7M Sell
368,787
-30,365
-8% -$3.13M 0.5% 43
2024
Q3
$45.3M Buy
399,152
+173,643
+77% +$20.6M 0.68% 31
2024
Q2
$27.9M Buy
225,509
+3,303
+1% +$425K 1.15% 16
2024
Q1
$29.3M Sell
222,206
-288,867
-57% -$35.6M 1.17% 16
2023
Q4
$55.7M Buy
511,073
+177,498
+53% +$18.4M 1.23% 15
2023
Q3
$34.3M Buy
333,575
+47,283
+17% +$5.1M 0.76% 29
2023
Q2
$33M Buy
286,292
+18,795
+7% +$2.13M 0.78% 33
2023
Q1
$28.5M Buy
267,497
+10,598
+4% +$1.14M 0.72% 34
2022
Q4
$28.5M Buy
+256,899
New +$26.3M 0.82% 28

Other funds holding MRK

LBP AM's MRK Position: Q1 2026 in Review

LBP AM reduced its Merck (MRK) stake by 48% in Q1 2026, selling an estimated $20.8M and leaving 196,922 shares worth $23.7M. The position accounts for 0.32% of the portfolio, ranked #60.

LBP AM first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $55.7M in Q4 2023. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • LBP AM held 196,922 shares of Merck worth $23.7M as of Q1 2026.
  • LBP AM sold 180,502 Merck shares in Q1 2026, an estimated $20.8M.
  • Merck made up 0.32% of LBP AM's portfolio in Q1 2026, its #60 holding.
  • LBP AM first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • LBP AM's Merck position peaked at $55.7M in Q4 2023.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.